Henri Termeer Henri Termeer has taken another fledgling drug developer under his wing. The former Genzyme CEO and chairman has joined the biotech Prosensa as a strategic adviser, bringing his experi…
A day after Isis Pharmaceuticals chairman and CEO Stanley Crooke told Scrip that the only program for which the antisense specialist was still seeking partners was in oncology the company announced a…
The chairman of the UK National Institute for Health and Clinical Excellence has said that if Roche were found to have withheld relevant data on its drug oseltamivir Tamiflu the companys medical...
* Roche says does not plan to combine CEO and chairman roles…
